Related Experiment Video

Updated: May 7, 2026

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

Helicobacter pylori infection among children with Phenylketonuria

Yeşim Oztürk1, Barış Erdur, Seçil Arslansoyu

  • 1Department of Pediatrics, Dokuz Eylul University Faculty of Medicine.

Japanese Journal of Infectious Diseases
|September 20, 2013
PubMed

Insights

Children with phenylketonuria (PKU) have a higher frequency of Helicobacter pylori infections, especially those with poor metabolic control. Further research is needed to understand this link.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Metabolic Disorders

Background:

  • Phenylketonuria (PKU) is a rare genetic disorder requiring strict dietary management.
  • Helicobacter pylori (H. pylori) infection is a common bacterial infection with varied clinical presentations.
  • The relationship between PKU and H. pylori infection has not been extensively studied.

Purpose of the Study:

  • To investigate the prevalence of H. pylori infections in children diagnosed with PKU.
  • To compare H. pylori infection rates between children with PKU and healthy controls.
  • To explore the association between H. pylori infection and metabolic control in PKU patients.

Main Methods:

  • A case-control study involving 66 children with PKU and 32 healthy controls.
  • H. pylori infection status determined through appropriate diagnostic methods.
  • Comparison of infection frequencies based on PKU status and metabolic control levels.

Main Results:

  • H. pylori infection was significantly more frequent in children with PKU (28.1%) compared to controls (9.4%).
  • Children with PKU and poor metabolic control exhibited a markedly higher infection rate (51.8%) than those with good control (10.2%).
  • No significant difference in WISC-R scores was observed between PKU subgroups with differing metabolic control.

Conclusions:

  • Children with PKU, particularly those with poor metabolic control, show an increased susceptibility to H. pylori infection.
  • The findings suggest a potential link between PKU metabolic status and H. pylori prevalence.
  • Further comprehensive clinical studies are warranted to elucidate the underlying mechanisms and implications of H. pylori infection in pediatric PKU.

More Related Videos

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance06:40

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance

Published on: July 28, 2023

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.